Back to results
TerminatedPhase 2

The Antidepressant Efficacy of the Anticholinergic Scopolamine

NCT00369915

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, United States

View on ClinicalTrials.gov
The Antidepressant Efficacy of the Anticholinergic Scopolamine — TrialFind